OakChart

OneMedNet Corp

ONMDHealthcare·Health Information Services·USA·Nano·NASD·Nov 11 • 1:51 PM ET

5.55-0.28 (-4.73%)
2026-11-11 19:52 CET
Market cap
34.99 USD m
Revenue, TTM
1.46 USD m
Net income, TTM
-8.51 USD m
Free cash flow, TTM
-6.70 USD m
EPS diluted, TTM
-1.56
P/E
-
Compare

Price

ONMD against its 20, 50 and 200-day averages
2050200
4.006.008.0010.0012.001.1M2.3MMay 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26ONMDclose 5.5520-day 4.7250-day 5.41200-day 7.045.5552w low

75.9% under the 52-week high of 23.00 on 28 Nov 2025. 52-week low 3.61 on 13 Oct 2026. Last 15 sessions, 51.0% high to low

Profile

ONMD
52-week range, 10% of the way up
3.6123.00

OneMedNet Corp. designs and develops clinical imaging technology for the healthcare sector. It offers OneMedNet iRWD, a solution that securely de-identifies, searches, curates and shares medical images data with patients, care providers, and hospitals. The company was founded by Jeffrey N. Yu in 2009 and is headquartered in Eden Prairie, MN.

Employees23
IPOJun 24, 2021
Beta1.19
ATR, 14d0.55
Rel volume0.21
Short float7.69%
Insider own71.19%
Inst own33.04%

Snapshot

6 groups

Valuation

Index-
Market Cap33.34M
Enterprise Value33.68M
Income-8.51M
Sales1.46M
Book/sh-0.61
Cash/sh0.06
Dividend Est.-
Dividend TTM-
Dividend Ex-Date-
Dividend Gr. 3/5Y- -
Payout-
Employees23
IPOJun 24, 2021

Ratios

P/E-
Forward P/E-
PEG-
P/S22.83
P/B-
P/C92.60
P/FCF-
EV/EBITDA-
EV/Sales23.07
Quick Ratio0.28
Current Ratio0.28
Debt/Eq-
LT Debt/Eq-
Option/ShortNo / Yes

Earnings

EPS (ttm)-1.56
EPS next Y-
EPS next Q-
EPS this Y-
EPS next Y-
EPS next 5Y-
EPS past 3/5Y- -
Sales past 3/5Y- -
EPS Y/Y TTM-17.08%
Sales Y/Y TTM216.52%
EPS Q/Q-148.22%
Sales Q/Q88.39%
EarningsNov 16 BMO
EPS/Sales Surpr.- -

Ownership

Insider Own71.19%
Insider Trans155.11%
Inst Own33.04%
Inst Trans22.34%
ROA-459.66%
ROE-
ROIC-
Gross Margin-71.22%
Oper. Margin-695.74%
Profit Margin-584.20%
SMA2017.41%
SMA502.46%
SMA200-21.21%
Trades-

Technical

Shs Outstand5.77M
Shs Float1.73M
Short Float7.69%
Short Ratio3.08
Short Interest0.13M
52W High23.00 -75.89%
52W Low3.61 53.60%
Volatility19.46% 10.53%
ATR (14)0.55
RSI (14)57.11
Beta1.19
Rel Volume0.21
Avg Volume43.16K
Volume6,101

Performance

Perf Week22.14%
Perf Month37.94%
Perf Quarter-28.64%
Perf Half Y-40.44%
Perf YTD-49.59%
Perf Year-62.79%
Perf 3Y-87.87%
Perf 5Y-94.49%
Perf 10Y-
Recom-
Target Price-
Prev Close5.82
Price5.55
Change %-4.73%

Peers

Mkt cap
TickerCompanyMkt cap
TEMTempus AI Inc14.72B
DHDefinitive Healthcare Corp180.78M
HCATHealth Catalyst Inc109.66M
OPRXOptimizeRx Corp182.02M
ACONAclarion Inc4.62M
SOPHSOPHiA Genetics SA667.82M
HTFLHeartflow Inc5.17B
BFRGBullfrog AI Holdings Inc10.41M
CCLDCareCloud Inc109.56M
NNOXNano X Imaging Ltd29.23M

Insider trading

latest 14 of 20
InsiderRelationshipDateTransactionCostSharesValueTotal heldForm
Kosasa ThomasDirectorOct 07 '26Buy5.78129,758750,0011,983,573Oct 13 08:32 PM
Yu JeffreyChief Medical OfficerOct 09 '26Buy5.5445,126249,998896,840Oct 13 08:32 PM
Golden Robert LawrenceChief Financial OfficerSep 21 '26Sale6.633,00019,89091,291Oct 09 09:30 PM
Golden Robert LawrenceChief Financial OfficerSep 15 '26Sale6.303,00018,90094,291Oct 09 09:30 PM
Golden Robert LawrenceChief Financial OfficerSep 14 '26Sale6.602,50016,50097,291Oct 09 09:30 PM
Green AaronChief Executive OfficerSep 22 '26Sale7.395,00036,960249,638Oct 09 09:30 PM
Green AaronChief Executive OfficerSep 24 '26Sale6.481,66710,802247,971Oct 09 09:30 PM
Yu JeffreyChief Medical OfficerSep 10 '26Buy0.63142,85790,0008,923,267Sep 14 08:47 PM
Kosasa ThomasDirectorJul 30 '26Buy0.691,449,2751,000,00018,538,150Aug 07 05:20 PM
Green AaronChief Executive OfficerJun 23 '26Buy0.5736,65021,0111,896,375Jun 24 09:00 AM
Yu JeffreyChief Medical OfficerJun 23 '26Buy0.63158,730100,0008,780,410Jun 24 09:00 AM
Yu JeffreyChief Medical OfficerJun 16 '26Buy0.58172,414100,0008,621,680Jun 17 07:38 AM
Green AaronChief Executive OfficerJun 12 '26Buy0.5636,92020,6051,841,023Jun 16 06:04 AM
Green AaronChief Executive OfficerJun 15 '26Buy0.5418,70210,0921,859,725Jun 16 06:04 AM

Held by

AUM
TickerCompanyAUM
VTIVanguard Morningstar Total Stock Market ETFAUM: 687.42B
VXFVanguard Extended Market Index ETFAUM: 30.47B
IWCiShares Micro-Cap ETFAUM: 1.22B
AVTMAvantis Total Equity Markets ETFAUM: 758.92M

News

latest 14 of 200
  • OneMedNet Reports $18.76 Million in Year-to-Date of Contracted Bookings and Publishes "OneMedNet by the Numbers" Growth Recap (GlobeNewswire) +16.73%
  • OneMedNet Partners to Combine First-Party Multimodal Clinical Data with Comprehensive Patient-Journey AI Analytics, Expanding Commercial Reach Through 13th Channel Partnership (GlobeNewswire)
  • OneMedNet Reports Preliminary Revenue for Third Quarter 2026 and Fourth Quarter 2026 Outlook (GlobeNewswire) +23.26%
  • OneMedNet Receives Mid Six-Figure Re-Order from Foundation Model Company Developing Radiology Models (GlobeNewswire) +7.84%
  • OneMedNet Receives High Six-Figure Add-On Order Under Multiyear Agreement Announced September 30 (GlobeNewswire)
  • OneMedNet Signs Global Pharmaceutical Intelligence Provider as Channel Partner, Extending Reach in Pharma Market (GlobeNewswire)
  • OneMedNet Adds Leading Hospital System Provider Network, Expanding By Up to 12 Hospitals (GlobeNewswire)
  • OneMedNet Signs Mediplexus as its 11th Channel Partner, Expanding the Company's Real World Data Footprint into Korea and the Asia Pacific Region (GlobeNewswire)
  • OneMedNet Signs Seven Figure Multiyear Agreement to Power a Partner Sold Derivative Data Solution (GlobeNewswire) +11.05%
  • OneMedNet Corporation Announces 1-for-10 Reverse Stock Split (GlobeNewswire) -7.80%
  • OneMedNet Expands Commercial Reach Through Multi-Year Resale Agreement with Atropos Health (GlobeNewswire) -5.48%
  • OneMedNet Reports Record Bookings as Faster Fulfillment Begins (GlobeNewswire) +14.57%
  • OneMedNet's iRWD Platform Enables Rapid Feasibility-to-Delivery for Leading AI-Driven Drug Development Company (GlobeNewswire)
  • OneMedNet Secures $11.5+ Million Agreement to Supply Regulatory-Grade Real-World Data for Foundational AI Model Development (GlobeNewswire) +17.02%

Quarterly earnings

actual against estimate
PeriodReportedEPS actEPS estEPS repSales actSales estAnalysts
No quarterly earnings.

Annual earnings

PeriodEPS actEPS estEPS repSales actSales est
No annual earnings.

Estimate revisions

last 14 periods
PeriodTypeDateEstimatesUpDownMeanLowHigh
No estimate revisions.

Estimate history

EPS, annual3.4330.278-47.685-3.608-0.629-1.5626
Period20212022202320242025TTM
EPS, quarterly-1.499-0.738-0.848-0.5580.776-0.141-0.604-0.443-0.374
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Sales, annual001.0210.6431.3591.46
Period20212022202320242025TTM
Sales, quarterly0.2270.1420.0260.1370.1550.1770.8910.0960.292
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26
Shares, annual1.4961.6342.3572.7995.1985.772
Period20212022202320242025MRQ
Shares, quarterly2.3862.7992.7993.0574.614.9735.1985.2795.772
PeriodQ2 '24Q3 '24Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26

Income statement, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Total Revenue1.461.360.641.020.000.00
Cost of Goods Sold Incl. D&A2.491.930.981.180.000.00
Gross Profit-1.04-0.57-0.34-0.160.000.00
Selling, General and Administrative Excl. Other9.099.109.276.705.100.42
Research and Development1.401.511.472.06--
Other Operating Expense0.000.000.000.000.210.16
Operating Income-10.13-9.67-9.61-6.85-5.31-0.59
Interest Expense0.030.070.150.010.000.00
Unusual Expense-1.88-6.030.4326.86-5.86-5.72
Net Income Before Taxes-8.51-2.80-10.13-33.760.555.14
Income Taxes0.000.000.000.020.210.00
Consolidated Net Income-8.51-2.80-10.13-33.780.345.14
Net Income From Continuing Operations-8.51-2.80-10.13-33.780.345.14
Net Income-8.51-2.80-10.13-33.780.345.14
EPS (Recurring)-1.69-1.58-3.50-21.14-3.100.76
EPS (Basic, Before Extraordinaries)-1.56-0.63-3.61-47.680.283.43
EPS (Diluted)-1.56-0.63-3.61-47.680.283.43
EBITDA-10.10-9.60-9.55-6.83-5.31-0.59
Non-Operating Income (Expense)-0.220.910.06-0.030.000.00
Other After Tax Adjustments0.000.000.000.000.000.00
Stock Option Compensation Expense2.091.610.501.172.23-
Price To Earnings Ratio----61.7929.42
Price To Sales Ratio28.3336.0659.385.62--
Gross Margin-71.22-41.80-52.57-15.38--
Operating Margin-695.74-711.33-1,493.78-671.20--
Net Margin-584.20-206.11-1,575.27-3,308.52--
Shares Outstanding5.775.202.802.361.631.50
Market Capitalization34.9934.9938.063.9236.13151.10

Income statement, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q12024Q42024Q3
Total Revenue0.290.100.890.180.150.140.030.14
Cost of Goods Sold Incl. D&A0.860.490.730.410.430.370.080.24
Gross Profit-0.57-0.390.16-0.23-0.28-0.24-0.05-0.09
Selling, General and Administrative Excl. Other1.692.163.242.001.791.992.612.29
Research and Development0.320.310.440.320.380.350.340.30
Other Operating Expense0.000.000.000.000.000.000.000.00
Operating Income-2.26-2.55-3.08-2.23-2.06-2.22-2.67-2.39
Interest Expense0.010.010.010.010.020.030.030.04
Unusual Expense-0.14-0.300.01-1.45-4.760.18-0.21-0.37
Net Income Before Taxes-2.17-2.45-3.14-0.742.98-1.90-2.37-2.06
Income Taxes0.000.000.000.000.000.000.000.00
Consolidated Net Income-2.17-2.45-3.14-0.742.98-1.90-2.37-2.06
Net Income From Continuing Operations-2.17-2.45-3.14-0.742.98-1.90-2.37-2.06
Net Income-2.17-2.45-3.14-0.742.98-1.90-2.37-2.06
EPS (Recurring)-0.39-0.48-0.60-0.33-0.09-0.52-0.90-0.83
EPS (Basic, Before Extraordinaries)-0.37-0.44-0.60-0.140.81-0.56-0.85-0.74
EPS (Diluted)-0.37-0.44-0.60-0.140.78-0.56-0.85-0.74
EBITDA-2.26-2.54-3.07-2.23-2.03-2.21-2.64-2.38
Non-Operating Income (Expense)-0.04-0.19-0.040.050.300.530.11-0.00
Other After Tax Adjustments0.000.000.000.000.000.000.000.00
Stock Option Compensation Expense0.460.431.060.140.200.210.050.21
Price To Sales Ratio28.3335.6542.05115.8747.6034.6259.2010.40
Gross Margin-195.21-407.2917.51-131.07-177.42-172.26-200.00-66.20
Operating Margin-774.32-2,658.33-345.90-1,262.71-1,330.97-1,623.36-10,253.85-1,680.99
Net Margin-743.84-2,555.21-352.41-418.641,923.87-1,388.32-9,130.77-1,449.30
Shares Outstanding5.775.285.204.974.613.062.802.80
Market Capitalization34.9944.8857.1854.2026.2816.5138.0617.11

Balance sheet, annual

Currency USD, millions
Metric2025FY2024FY2023FY2022FY2021FY
Cash & Short Term Investments1.093.020.050.030.45
Short Term Receivables0.490.210.150.000.00
Inventories0.000.000.000.000.00
Other Current Assets0.510.390.170.000.08
Total Current Assets2.103.620.360.030.54
Net Property, Plant & Equipment0.060.110.100.000.00
Total Investments and Advances0.000.000.0029.03117.32
Intangible Assets0.000.000.000.000.00
Other Assets0.000.000.000.000.00
Total Assets2.153.730.4629.06117.86
Short Term Debt Incl. Current Port. of LT Debt0.759.388.150.000.00
Accounts Payable3.506.044.680.000.00
Income Tax Payable---0.280.16
Other Current Liabilities0.573.810.541.690.13
Total Current Liabilities4.8319.2313.371.980.29
Long Term Debt0.220.000.470.000.00
Provision for Risks Charges0.000.000.000.000.00
Other Liabilities0.070.450.077.148.88
Total Liabilities5.1219.6813.919.129.17
Non-Equity Reserves0.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.00
Common Equity-2.96-15.95-13.4419.94108.69
Total Shareholders Equity-2.96-15.95-13.4419.94108.69
Accumulated Minority Interest0.000.000.000.000.00
Total Equity-2.96-15.95-13.4419.94108.69
Total Liabilities & Stockholders Equity2.153.730.4629.06117.86
Book Value Per Share-0.57-5.70-5.7012.2172.65
Tangible Book Value Per Share-0.57-5.70-5.7012.2172.65
Full-Time Employees23222022
Price to Book Ratio-9.55-2.390.521.401.39
Return on Assets-95.30-483.37-228.830.46-
Return on Equity---1,039.120.52-
Return on Invested Capital---1.694.73
Quick Ratio0.430.190.030.021.85
Current Ratio0.430.190.030.021.85

Cash flow, annual

Currency USD, millions
MetricTTM2025FY2024FY2023FY2022FY2021FY
Net Income-8.51-2.80-10.13-33.780.345.14
Depreciation0.040.070.060.03--
Other Funds (Non Cash)0.80-4.871.5828.35-3.030.60
Funds from Operations-7.67-7.61-8.49-5.40-2.705.74
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital0.990.111.540.611.76-6.12
Income Taxes Payable----0.120.16
Cash from Operating Activities-6.69-7.50-6.95-4.79-0.94-0.38
Capital Expenditures-0.02-0.01-0.05-0.040.000.00
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments1.062.32-1.930.00-2.55-117.30
Purchase of Investments-0.55-2.75-2.900.00-2.55-117.30
Sale Or Maturity of Investments1.615.070.970.000.000.00
Other Uses0.000.000.000.000.000.00
Other Sources0.420.000.000.000.300.00
Cash from Investing Activities1.472.31-1.98-0.04-2.25-117.30
Cash Dividends Paid0.000.000.000.000.000.00
Change in Capital Stock3.603.736.170.020.00118.13
Repurchase of Common Pref Stock0.000.000.000.000.000.00
Sale of Common Pref Stock3.603.736.170.020.00118.13
Proceedsfrom Stock Options3.493.676.170.020.00118.13
Issuance or Reduction of Debt, Net1.861.871.546.132.760.00
Change in Long Term Debt-0.41-0.401.546.132.760.00
Issuance of Long Term Debt0.000.002.506.132.760.08
Reduction of Long Term Debt-0.41-0.40-0.960.000.00-0.08
Net Financing Active Other Cash Flow0.000.001.35-1.530.000.00
Other Financing Activities Uses0.000.000.00-1.530.000.00
Cash from Financing Activities5.465.619.064.612.76118.13
Net Change in Cash0.240.410.12-0.22-0.420.45
Free Cash Flow-6.70-7.52-7.00-4.83-0.94-0.38
Preferred Dividends (Cash Flow)-0.000.000.000.000.00
Deferred Taxes & Investment Tax Credit-0.000.000.000.000.00

Balance sheet, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Cash & Short Term Investments0.360.231.090.751.720.94
Short Term Receivables0.660.700.490.580.250.25
Inventories0.000.000.000.000.000.00
Other Current Assets0.290.530.510.120.290.45
Total Current Assets1.311.462.101.452.271.63
Net Property, Plant & Equipment0.050.050.060.060.070.10
Total Investments and Advances0.000.000.000.000.000.00
Intangible Assets0.000.000.000.000.000.00
Other Assets0.000.000.000.000.000.00
Total Assets1.361.512.151.512.341.73
Short Term Debt Incl. Current Port. of LT Debt0.570.660.750.390.407.52
Accounts Payable3.473.943.503.855.256.87
Other Current Liabilities0.680.750.570.770.513.77
Total Current Liabilities4.735.364.835.006.1618.15
Long Term Debt0.130.180.220.000.000.00
Provision for Risks Charges0.000.000.000.000.000.00
Other Liabilities0.020.060.070.440.020.13
Total Liabilities4.885.595.125.456.1818.28
Non-Equity Reserves0.000.000.000.000.000.00
Preferred Stock - Carrying Value0.000.000.000.000.000.00
Common Equity-3.52-4.08-2.96-3.94-3.84-16.55
Total Shareholders Equity-3.52-4.08-2.96-3.94-3.84-16.55
Accumulated Minority Interest0.000.000.000.000.000.00
Total Equity-3.52-4.08-2.96-3.94-3.84-16.55
Total Liabilities & Stockholders Equity1.361.512.151.512.341.73
Book Value Per Share-0.61-0.77-0.57-0.79-0.83-5.41
Tangible Book Value Per Share-0.61-0.77-0.57-0.79-0.83-5.41
Full-Time Employees--23---
Price to Book Ratio-9.55-11.00-19.29-13.76-6.84-1.00
Return on Assets-459.66-206.98-95.30-69.05-198.46-799.60
Quick Ratio0.280.270.430.290.370.09
Current Ratio0.280.270.430.290.370.09

Cash flow, quarterly

Currency USD, millions
Metric2026Q22026Q12025Q42025Q32025Q22025Q1
Net Income-2.17-2.45-3.14-0.742.98-1.90
Depreciation0.010.010.010.010.030.01
Other Funds (Non Cash)0.370.321.47-1.37-4.86-0.12
Funds from Operations-1.80-2.12-1.66-2.10-1.84-2.01
Extraordinary Item0.000.000.000.000.000.00
Changes in Working Capital-0.070.58-0.060.54-0.440.06
Cash from Operating Activities-1.88-1.54-1.71-1.56-2.28-1.95
Capital Expenditures-0.01-0.00-0.010.00-0.00-0.01
Net Assets From Acquisitions0.000.000.000.000.000.00
Sale of Fixed Assets and Businesses0.000.000.000.000.000.00
Purchase or Sale of Investments0.000.00-0.051.11-0.671.93
Purchase of Investments0.000.00-0.35-0.20-2.200.00
Sale Or Maturity of Investments0.000.000.301.311.531.93
Other Uses0.000.000.000.000.000.00
Other Sources0.070.350.000.000.000.00
Cash from Investing Activities0.060.35-0.051.11-0.671.92
Cash Dividends Paid0.000.000.000.000.000.00
Preferred Dividends (Cash Flow)0.000.00--0.000.00
Change in Capital Stock2.080.970.050.493.190.00
Repurchase of Common Pref Stock0.000.000.01-0.010.000.00
Sale of Common Pref Stock2.080.970.040.503.190.00
Proceedsfrom Stock Options2.510.50-0.020.503.190.00
Issuance or Reduction of Debt, Net-0.14-0.142.15-0.01-0.260.00
Change in Long Term Debt-0.14-0.14-0.13-0.01-0.260.00
Issuance of Long Term Debt0.000.000.000.000.000.00
Reduction of Long Term Debt-0.14-0.14-0.13-0.01-0.260.00
Net Financing Active Other Cash Flow0.000.000.000.000.000.00
Other Financing Activities Uses0.000.000.000.000.000.00
Cash from Financing Activities1.940.842.200.482.930.00
Net Change in Cash0.12-0.350.440.03-0.02-0.03
Free Cash Flow-1.88-1.54-1.72-1.56-2.29-1.95

Revenue breakdown

Data Delivery2024: 292.00K 2025: 1.25M
Subscription2024: 351.00K 2025: 105.00K
Americas2024: 401.00K 2025: 608.00K
Asia Pacific2025: 56.00K
EMEA2024: 242.00K 2025: 695.00K

Short interest

shares short against float, oldest to newest
SettlementOf floatShares shortFloatAvg volume
2026-10-307.69%0.1M1.7M48.81K
2026-10-158.73%0.2M1.7M116.65K
2026-09-305.68%0.1M2.0M112.91K
2026-09-154.69%0.1M2.0M105.65K
2026-08-315.08%0.1M1.7M106.48K
2026-08-144.18%0.1M1.7M106.89K
2026-07-3111.05%0.2M1.6M100.94K
2026-07-152.10%0.0M1.6M51.83K
2026-06-301.42%0.0M1.6M54.90K
2026-06-153.19%0.1M1.6M51.79K
2026-05-292.73%0.0M1.7M70.60K
2026-05-153.74%0.1M1.5M414.80K
2026-04-305.17%0.1M1.4M420.50K
2026-04-153.94%0.1M1.6M406.18K
2026-03-314.82%0.1M1.6M407.28K
2026-03-1311.20%0.2M1.5M411.17K
2026-02-272.05%0.0M1.5M446.79K
2026-02-132.13%0.0M1.5M110.50K
2026-01-301.46%0.0M1.5M112.10K
2026-01-150.88%0.0M1.5M119.60K

Option chain

expiry 2026-11-11
TypeStrikeBidAskLastIVOpen intVolumeDeltaThetaVega
No option chain for this symbol.

Latest SEC filings

30
FiledFormDescriptionPeriodLink
2026-11-098-KCurrent report2026-11-09SEC
2026-11-068-KCurrent report2026-11-06SEC
2026-10-148-KCurrent report2026-10-13SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-07SEC
2026-10-134Statement of changes in beneficial ownership of securities2026-10-09SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-07-06SEC
2026-10-094Statement of changes in beneficial ownership of securities2026-01-01SEC
2026-09-30424B3SEC
2026-09-30424B3SEC
2026-09-298-KCurrent report2026-09-26SEC
2026-09-238-KCurrent report2026-09-18SEC
2026-09-144Statement of changes in beneficial ownership of securities2026-09-10SEC
2026-08-20424B3SEC
2026-08-20424B3SEC
2026-08-19DEF 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-08-19SEC
2026-08-1410-QQuarterly report pursuant to Section 13 or 15(d)2026-06-30SEC
2026-08-074Statement of changes in beneficial ownership of securities2026-07-30SEC
2026-08-07PRE 14AProxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 19342026-08-07SEC
2026-07-248-KCurrent report2026-07-24SEC
2026-07-13424B3SEC
2026-07-10EFFECTEffectiveness filing by commission orderSEC
2026-07-08S-1/ASEC
2026-07-01S-1General form of registration statement for all companies including face-amount certificate companiesSEC
2026-07-018-KCurrent report2026-07-01SEC
2026-06-244Statement of changes in beneficial ownership of securities2026-06-23SEC
2026-06-244Statement of changes in beneficial ownership of securities2026-06-23SEC
2026-06-174Statement of changes in beneficial ownership of securities2026-06-16SEC
2026-06-164Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-06-154Statement of changes in beneficial ownership of securities2026-06-12SEC
2026-05-204Statement of changes in beneficial ownership of securities2026-05-18SEC

Insider activity by month

MonthBoughtBuysSoldSells
2026-110000
2026-101000.00K200
2026-0990.00K1103.05K5
2026-080000
2026-071000.00K100
2026-06351.71K600
2026-05250.00K100
2026-041000.00K200
2026-030000
2026-02500.00K100
2026-010000
2025-120000
2025-110073.90K1

Institutional holders

Manager% owned
Savant Capital, LLC24.35%
VANGUARD CAPITAL MANAGEMENT LLC2.12%
GEODE CAPITAL MANAGEMENT, LLC0.48%
VANGUARD FIDUCIARY TRUST CO0.25%
BlackRock, Inc.0.22%
STATE STREET CORP0.21%
DISCOVERY CAPITAL MANAGEMENT, LLC / CT0.21%
OpenArc Corporate Advisory, LLC0.18%
PNC FINANCIAL SERVICES GROUP, INC.0.17%
NORTHERN TRUST CORP0.09%

Funds

Fund% owned
VANGUARD TOTAL STOCK MARKET INDEX FUND1.55%
VANGUARD EXTENDED MARKET INDEX FUND0.56%
Fidelity Extended Market Index Fund0.24%
iShares Micro-Cap ETF0.09%
Fidelity Total Market Index Fund0.07%
Fidelity Series Total Market Index Fund0.07%
Fidelity Nasdaq Composite Index Fund0.05%
1290 VT Micro Cap Portfolio0.01%
Avantis Total Equity Markets ETF0.00%
Blackstone Alternative Multi-Strategy Fund-0.01%

OakChart. ONMD. Cached 15 minutes.

Some panels did not load: ratings.